These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30420710)

  • 1. Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells.
    Pontremoli M; Brioschi M; Baetta R; Ghilardi S; Banfi C
    Sci Rep; 2018 Nov; 8(1):16671. PubMed ID: 30420710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation.
    Baetta R; Lento S; Ghilardi S; Barbati E; Corsini A; Tremoli E; Banfi C
    Vascul Pharmacol; 2015; 67-69():38-47. PubMed ID: 25849951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-CoA reductase inhibitors.
    Brioschi M; Lento S; Tremoli E; Banfi C
    J Proteomics; 2013 Jan; 78():346-61. PubMed ID: 23085226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.
    Rachner TD; Göbel A; Thiele S; Rauner M; Benad-Mehner P; Hadji P; Bauer T; Muders MH; Baretton GB; Jakob F; Ebert R; Bornhäuser M; Schem C; Hofbauer LC
    Breast Cancer Res; 2014 Feb; 16(1):R20. PubMed ID: 24528599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.
    Göbel A; Browne AJ; Thiele S; Rauner M; Hofbauer LC; Rachner TD
    Breast Cancer Res Treat; 2015 Dec; 154(3):623-31. PubMed ID: 26515701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction.
    Ueland T; Butt N; Lekva T; Ørn S; Manhenke C; Aukrust P; Larsen AI
    Int J Cardiol; 2024 Jul; 406():132035. PubMed ID: 38604450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.
    Lopez S; Peiretti F; Bonardo B; Juhan-Vague I; Nalbone G
    Atherosclerosis; 2000 Oct; 152(2):359-66. PubMed ID: 10998463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dkk (Dickkopf) Proteins.
    Baetta R; Banfi C
    Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1330-1342. PubMed ID: 31092014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK.
    Pedrini S; Carter TL; Prendergast G; Petanceska S; Ehrlich ME; Gandy S
    PLoS Med; 2005 Jan; 2(1):e18. PubMed ID: 15647781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion.
    Kofler S; Schlichting C; Jankl S; Nickel T; Weis M
    Atherosclerosis; 2008 Mar; 197(1):105-10. PubMed ID: 17888931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity.
    Swiatkowska M; Pawlowska Z; Szemraj J; Drzewoski J; Watala C; Cierniewski CS
    Jpn J Pharmacol; 2002 Dec; 90(4):337-44. PubMed ID: 12501010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes.
    Ishibashi T; Nagata K; Ohkawara H; Sakamoto T; Yokoyama K; Shindo J; Sugimoto K; Sakurada S; Takuwa Y; Teramoto T; Maruyama Y
    Biochim Biophys Acta; 2002 Jun; 1590(1-3):123-30. PubMed ID: 12063175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins.
    Essig M; Nguyen G; Prié D; Escoubet B; Sraer JD; Friedlander G
    Circ Res; 1998 Oct; 83(7):683-90. PubMed ID: 9758637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the endothelial plasminogen activator system by fluvastatin. Role of Rho family proteins, actin polymerisation and p38 MAP kinase.
    Dunoyer-Geindre S; Fish RJ; Kruithof EK
    Thromb Haemost; 2011 Mar; 105(3):461-72. PubMed ID: 21174002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Adding Eicosapentaenoic Acid to Statin Therapy on Plasma Pentraxin 3 Level in Patients with Stable Coronary Artery Disease: A 6-Month, Randomized Controlled Study.
    Tani S; Nagao K; Yagi T; Atsumi W; Hirayama A
    Am J Cardiovasc Drugs; 2017 Feb; 17(1):49-59. PubMed ID: 27778191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin affects several angiogenic mediators in human endothelial cells.
    Dulak J; Loboda A; Jazwa A; Zagorska A; Dörler J; Alber H; Dichtl W; Weidinger F; Frick M; Jozkowicz A
    Endothelium; 2005; 12(5-6):233-41. PubMed ID: 16410222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.